Comparative simulation of intraperitoneal aminoglycoside regimens for patients with peritonitis on automated peritoneal dialysis

CONCLUSIONS: The current international guidelines for the treatment of peritoneal dialysis-associated peritonitis can continue to recommend the fixed-dose regimen for those on APD with the addition of plasma Cmin monitoring after 3 days to assess for drug accumulation.PMID:38288583 | DOI:10.1177/08968608231221062

Source: Peritoneal Dialysis International - January 30, 2024 Category: Urology & Nephrology Authors: Robert E Ariano Sheryl A Zelenitsky Christine Davis Christie Sathianathan William R Wolowich Source Type: research